Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
Reports: Shein Files for Initial Public Offering
Online fashion retailer Sheen is reportedly said to go public. Multiple media outlets reported that the Chinese-founded company has filed confidentially for an initial public offering in the U.S.
Load More